Skip to main content
Back to Menlo Ventures

Menlo Ventures's Life Science Portfolio

Browse 8 Life Science companies funded by Menlo Ventures. See funding amounts, founder contacts, and investment details.

Life Science Companies
8
Total Funding in Life Science
$668.5M

Life Science Portfolio Companies (8)

Export
BiotechnologyLife ScienceTherapeutics

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Alameda, United States
July 2026
$7.5M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)Foundational AIHealth CareLife Science

Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design.

San Francisco, United States
July 2026
$400.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceMachine LearningPharmaceutical

Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.

Lexington, United States
June 2022
$30.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalTherapeutics

H1 is on a mission to connect the world to the right doctor

New York, United States
May 2026
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyGeneticsIndustrial AutomationInnovation ManagementLife ScienceMachine LearningSoftware

Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.

Redwood City, United States
February 2022
$200.0M
Series E

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)Life ScienceSoftware

Bluenote Health operates as an AI platform for life sciences.

San Francisco, United States
December 2024
$10.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth DiagnosticsLife ScienceMedical

Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.

Seattle, United States
June 2024
$21.0M
Series A

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceSoftware

Benchling is an IT company that provides a cloud-based software platform for biology researchers and research and development organizations.

San Francisco, United States
November 2021
Series F

Founder Contacts

41,000+ verified contacts

Explore Menlo Ventures's Full Portfolio

View all companies funded by Menlo Ventures across every industry and funding stage.

View Full Menlo Ventures Portfolio